60 Degrees Pharmaceuticals, Inc.
SXTP
$1.75
-$0.11-5.91%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -130.84% | 82.65% | 90.66% | 39.08% | 41.57% |
| Total Depreciation and Amortization | -27.57% | -11.27% | 11.00% | 27.45% | 29.85% |
| Total Amortization of Deferred Charges | -163.87% | -143.16% | -123.11% | -95.99% | 1.69% |
| Total Other Non-Cash Items | 221.99% | -207.59% | -355.23% | -338.04% | -564.28% |
| Change in Net Operating Assets | 315.09% | -127.84% | -109.13% | -87.97% | -89.39% |
| Cash from Operations | 10.38% | -459.03% | -299.23% | -349.76% | -262.00% |
| Capital Expenditure | -8,766.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,590.95% | -11.07% | -3.51% | 3.00% | -3,115.15% |
| Cash from Investing | -1,710.57% | -198.85% | -95.53% | -92.85% | -3,169.70% |
| Total Debt Issued | -100.00% | -100.00% | -53.03% | -30.25% | -8.71% |
| Total Debt Repaid | 100.00% | -544.44% | -- | -- | -- |
| Issuance of Common Stock | -5.69% | -- | 5,029.84% | 3,993.96% | 3,993.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 53.38% | 87.91% | -72.85% | -119.24% | -- |
| Cash from Financing | 10.09% | 1,710.42% | 483.68% | 429.97% | 366.20% |
| Foreign Exchange rate Adjustments | 115.59% | 505.66% | 162.30% | 3,042.86% | 326.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.18% | 312.66% | 3,744.66% | 1,155.92% | 1,614.07% |
